Tag: Prescription Drugs
Risk for Conversion of MS Varies With Different Therapies
Lower risk for conversion for initial treatment with fingolimod, alemtuzumab, or natalizumab
USPSTF Recommends Risk-Reducing Meds for Breast Cancer
Risk-reducing medications recommended for women at high risk, not for routine use
Median Survival for Stage 4 ALK-Positive NSCLC Nearly 7 Years
Most patients in study received crizotinib; prognosis worse when more organs have tumors at diagnosis
Drug Repurposing May Provide More Psychiatric Tx Options
Three drug classes tied to lower rates of self-harm and psychiatric stays with serious mental illness
Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
Rising costs of oral, injectable generic and specialty drugs mostly driven by new product entry
No Increased Fall Risk With HTN Treatment in Older Women
Lower incidence rate ratios found for women with treated controlled hypertension, treated uncontrolled HTN
Exercise Can Consistently Lower Blood Pressure
Reductions in BP from exercise comparable but not as great as from medications
Gabapentin Improves Sexual Function in Provoked Vulvodynia
Sexual function improved for gabapentin vs. placebo, but still lower than among matched pain-free controls
Multimethod Approach Improves ID of Med Nonadherence
Use of provider report, medication possession ratio improved ID of nonadherence in youth with CKD
Rituximab Beneficial in Secondary Progressive MS
Treatment with rituximab linked to lower Expanded Disability Status Scale score, delayed progression
